Medical journal requirements for clinical trial data sharing: Ripe for improvement
| Autor: | Ioana A. Cristea, Ulrich Mansmann, Maximilian Siebert, Christian Ohmann, Jeanne Fabiola Gaba, Claude Pellen, Valentin Danchev, John P. A. Ioannidis, David Moher, Florian Naudet, Joshua D. Wallach, Cathrine Axfors |
|---|---|
| Přispěvatelé: | Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Uppsala University, Stanford University, University of Pavia, Ludwig-Maximilians-Universität München (LMU), European Clinical Research Infrastructures Network [Dusseldorf] (ECRIN), Yale School of Public Health (YSPH), Ottawa Hospital Research Institute [Ottawa] (OHRI), FN received funding from the French National Research Agency for the ReiTheR (Reproducibility in Therapeutic Research) project, that this article was part of. Project Number: ANR-17-CE36-0010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., ANR-17-CE36-0010,ReiTheR,Reproductibilité de la recherche thérapeutique(2017), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Università degli Studi di Pavia = University of Pavia (UNIPV), Jonchère, Laurent, Reproductibilité de la recherche thérapeutique - - ReiTheR2017 - ANR-17-CE36-0010 - AAPG2017 - VALID |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Biomedical Research
Medical Journals [SDV]Life Sciences [q-bio] Publication Ethics law.invention 0302 clinical medicine Randomized controlled trial law Medicine and Health Sciences 030212 general & internal medicine Research Integrity Clinical Trials as Topic Policy Forum Public Health Global Health Social Medicine and Epidemiology General Medicine Research Assessment Reproducibility 3. Good health [SDV] Life Sciences [q-bio] Policy Publication ethics Medicine Science policy Periodicals as Topic medicine.medical_specialty Drug Research and Development Science Policy MEDLINE Research and Analysis Methods 03 medical and health sciences Stakeholder Participation medicine Humans Clinical Trials Medical physics Medical journal Scientific Publishing Pharmacology Health Care Policy Information Dissemination business.industry Randomized Controlled Trials Health Care Clinical trial Data sharing Folkhälsovetenskap global hälsa socialmedicin och epidemiologi Clinical Medicine Scientific publishing business Medical Humanities 030217 neurology & neurosurgery |
| Zdroj: | PLoS Medicine PLoS Medicine, Public Library of Science, 2021, 18 (10), pp.e1003844. ⟨10.1371/journal.pmed.1003844⟩ PLoS Medicine, 2021, 18 (10), pp.e1003844. ⟨10.1371/journal.pmed.1003844⟩ PLoS Medicine, Vol 18, Iss 10 (2021) PLoS Medicine, Vol 18, Iss 10, p e1003844 (2021) |
| ISSN: | 1549-1277 1549-1676 |
| Popis: | Summary points: Efficient sharing and reuse of data from clinical trials are critical in advancing medical knowledge and developing improved treatments. We believe that the International Committee of Medical Journal Editors (ICMJE) clinical trial data sharing policy is currently inadequate. Although data sharing plans help increase transparency, they do not ensure that data are shared, and they are often inadequately implemented. We believe that the ICMJE should adapt a stronger policy on data sharing that is enforced rigorously in all ICMJE members and affiliated journals. The policy should include a strong evaluation component to ensure that all clinical trial data are shared, their value maximized, and data producers incentivized. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|